Back
PT Bank Central Asia Tbk Vs. Eli Lilly and Industry Stock Comparison
Sell
48
PBCRF
PT Bank Central Asia Tbk
Last Price:
$0.52
Seasonality Move:
6.26%
Buy
56
LLY
Eli Lilly and
Last Price:
$715.65
Seasonality Move:
2.04%
Sell
48
PT Bank Central Asia Tbk (PBCRF)
is a Sell
Is PT Bank Central Asia Tbk a Buy, Sell or Hold?
-
The current PT Bank Central Asia Tbk [PBCRF] share price is $0.52. The Score for PBCRF is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
PBCRF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Eli Lilly and (LLY)
is a Buy
Is Eli Lilly and a Buy, Sell or Hold?
-
The current Eli Lilly and [LLY] share price is $746.06. The Score for LLY is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
LLY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PBCRF Stock Price Chart
What is PT Bank Central Asia Tbk's stock price today?
-
The PT Bank Central Asia Tbk share price today is $0.52Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PBCRF is experiencing slight buying pressure.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $746.06Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing slight selling pressure.
PBCRF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 61.67 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.44 - 0.52) | Buy |
Bollinger Bands (100): | (0.48 - 0.58) | Sell |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -15.15 | Sell |
Relative Strength Index (14 RSI): | 40.98 | Sell |
Chaikin Money Flow: | -1951707 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (739.66 - 850.66) | Sell |
Bollinger Bands (100): | (759.96 - 866.44) | Sell |
PBCRF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.52 | Buy |
20-day SMA: | 0.5 | Buy |
50-day SMA: | 0.5 | Buy |
200-day SMA: | 0.6 | Sell |
8-day EMA: | 0.52 | Buy |
20-day EMA: | 0.5 | Buy |
50-day EMA: | 0.51 | Buy |
200-day EMA: | 0.56 | Sell |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 773.07 | Sell |
20-day SMA: | 809.57 | Sell |
50-day SMA: | 814.92 | Sell |
200-day SMA: | 839.53 | Sell |
8-day EMA: | 771.09 | Sell |
20-day EMA: | 793.34 | Sell |
50-day EMA: | 807.74 | Sell |
200-day EMA: | 812.35 | Sell |
PT Bank Central Asia Tbk Earnings Growth & PBCRF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.36 per share, an increase next quarter of $0.99 per share, an increase this year of $8.96 per share, and an increase next year of $7.77 per share.
PT Bank Central Asia Tbk Technical Analysis
Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |